R E Fischer-Betz

Summary

Affiliation: Heinrich Heine University
Country: Germany

Publications

  1. doi request reprint [Biologics during pregnancy and breast--feeding]
    R E Fischer-Betz
    Klinik für Endokrinolologie, Diabetologie und Rheumatologie, Rheumazentrum Rhein Ruhr, Moorenstr 5, 40225, Dusseldorf
    Z Rheumatol 69:780-7. 2010
  2. doi request reprint [Early lupus erythematosus]
    R Fischer-Betz
    Poliklinik fur Rheumatologie, Heinrich Heine Universitat, Moorenstr 5, 40225, Dusseldorf, Deutschland
    Z Rheumatol 72:948-53. 2013
  3. doi request reprint [Pregnancy and inflammatory rheumatic diseases]
    R Fischer-Betz
    Poliklinik fur Rheumatologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225, Dusseldorf, Deutschland
    Z Rheumatol 72:669-82. 2013
  4. doi request reprint Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study
    Rebecca Fischer-Betz
    Department of Endocrinology, Diabetology and Rheumatology and the Department of Nephrology, Heinrich Heine University, Duesseldorf, Germany
    J Rheumatol 39:2111-7. 2012
  5. doi request reprint [Recommendation for use of belimumab for systemic lupus erythematosus]
    R Fischer-Betz
    Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Rheumazentrum Rhein Ruhr, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225, Dusseldorf, Deutschland
    Z Rheumatol 72:462-7. 2013
  6. doi request reprint Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine
    Rebecca Fischer-Betz
    Department of Rheumatology, Heinrich Heine University, Moorenstr 5, 40225 Dusseldorf, Germany
    Rheumatology (Oxford) 52:1070-6. 2013
  7. doi request reprint Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study
    R Fischer-Betz
    Heinrich Heine University, Endocrinology, Diabetology and Rheumatology, Germany
    Lupus 21:1183-9. 2012
  8. doi request reprint [Rheumatic diseases during pregnancy]
    R Fischer-Betz
    Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225 Dusseldorf, Deutschland
    Internist (Berl) 53:1047-53. 2012
  9. pmc Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
    Hans Peter Tony
    Medizinische Klinik und Poliklinik II, Universitatsklinikum Wurzburg, Klinikstr 6 8, 97070 Wurzburg, Germany
    Arthritis Res Ther 13:R75. 2011
  10. ncbi request reprint Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra)
    Rebecca Fischer-Betz
    Department of Endocrinology, Heinrich Heine University, Duesseldorf, Germany
    Clin Exp Rheumatol 29:1021-3. 2011

Collaborators

  • M Schneider
  • Ralph Brinks
  • Stefan Vordenbäumen
  • Martin Aringer
  • Christof Specker
  • DD Singh
  • F Hiepe
  • J Richter
  • O Sander
  • A Zink
  • G Chehab
  • Christof Iking-Konert
  • J Listing
  • Hans Peter Tony
  • M Haupt
  • Mathias Grunke
  • Elvira Schmidt
  • Enno Schmidt
  • Rüdiger Eming
  • Nico Hunzelmann
  • Roland Veelken
  • Waltraud Jakob
  • Andrea Rubbert-Roth
  • Gerd Burmester
  • Michael Hertl
  • Joerg Henes
  • Heinz Wiendl
  • Helmut Sörensen
  • Judith Haas
  • Klaus Freivogel
  • Klemens Budde
  • Praxis von Wussow
  • Bernd Kieseier
  • Cornelia Erfurt-Berge
  • Uwe Zettl
  • Michael Sticherling
  • Thomas Dorner
  • Frank Strutz
  • Marion Haubitz
  • Christoph Fiehn
  • Jutta Weinerth
  • Florian M P Meier
  • Siegfried Wassenberg
  • Stefan Heitmann
  • Ulf Ziemann
  • Ina Kotter
  • Andreas Schwarting
  • Michael Meurer
  • Michael Schwarz-Eywill
  • Rudolf Stadler
  • Raoul Bergner
  • Julia Holle
  • Svjetlana Lovric
  • Leonore Unger
  • Ramona König
  • Jens Westphal
  • Hendrik Schulze-Koops
  • Anna L Herzog
  • Martin Fleck
  • Philip Burgwinkel
  • Ulf Müller-Ladner
  • Claudia Metzler
  • S Millen
  • M Janner
  • D Falagan

Detail Information

Publications25

  1. doi request reprint [Biologics during pregnancy and breast--feeding]
    R E Fischer-Betz
    Klinik für Endokrinolologie, Diabetologie und Rheumatologie, Rheumazentrum Rhein Ruhr, Moorenstr 5, 40225, Dusseldorf
    Z Rheumatol 69:780-7. 2010
    ..The use of these agents is likely compatible with breast-feeding. The extent of fetal risk is not clarified for exposure to other biologics, such as Rituximab...
  2. doi request reprint [Early lupus erythematosus]
    R Fischer-Betz
    Poliklinik fur Rheumatologie, Heinrich Heine Universitat, Moorenstr 5, 40225, Dusseldorf, Deutschland
    Z Rheumatol 72:948-53. 2013
    ..Early intervention should prevent increasing damage. Key elements of medical treatment are antimalarial agents. Furthermore, control of co-morbidities and optimization of lifestyle are crucial...
  3. doi request reprint [Pregnancy and inflammatory rheumatic diseases]
    R Fischer-Betz
    Poliklinik fur Rheumatologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225, Dusseldorf, Deutschland
    Z Rheumatol 72:669-82. 2013
    ..A careful assessment of possible risks and the justified use of antirheumatic drugs before, during and after pregnancy are key issues. ..
  4. doi request reprint Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study
    Rebecca Fischer-Betz
    Department of Endocrinology, Diabetology and Rheumatology and the Department of Nephrology, Heinrich Heine University, Duesseldorf, Germany
    J Rheumatol 39:2111-7. 2012
    ..However, the optimal dose of corticosteroids needed has not been defined. We evaluated the efficacy of a monotherapy with IV CYC in patients with a first episode of LN (duration ≤ 6 months)...
  5. doi request reprint [Recommendation for use of belimumab for systemic lupus erythematosus]
    R Fischer-Betz
    Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Rheumazentrum Rhein Ruhr, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225, Dusseldorf, Deutschland
    Z Rheumatol 72:462-7. 2013
    ..Due to lacking data the use of belimumab is not recommended for the purpose of treating severe active SLE with renal or central nervous system involvement until efficacy has been shown for these indications...
  6. doi request reprint Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine
    Rebecca Fischer-Betz
    Department of Rheumatology, Heinrich Heine University, Moorenstr 5, 40225 Dusseldorf, Germany
    Rheumatology (Oxford) 52:1070-6. 2013
    ..This change may lead to flares. Our aim was to determine the risk of renal flares in women with LN who switched treatment from MMF to AZA before conception and to evaluate the outcome of their pregnancies...
  7. doi request reprint Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study
    R Fischer-Betz
    Heinrich Heine University, Endocrinology, Diabetology and Rheumatology, Germany
    Lupus 21:1183-9. 2012
    ..15). Despite treatment, there is a significant risk for pregnancy complications in APS patients with previous CVE. Especially in the context of preeclampsia, anticoagulation should be given rigorously to prevent recurrence of CVE...
  8. doi request reprint [Rheumatic diseases during pregnancy]
    R Fischer-Betz
    Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225 Dusseldorf, Deutschland
    Internist (Berl) 53:1047-53. 2012
    ..A careful assessment of possible risks and the justified use of antirheumatic drugs before, during and after pregnancy are key issues for success...
  9. pmc Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
    Hans Peter Tony
    Medizinische Klinik und Poliklinik II, Universitatsklinikum Wurzburg, Klinikstr 6 8, 97070 Wurzburg, Germany
    Arthritis Res Ther 13:R75. 2011
    ....
  10. ncbi request reprint Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra)
    Rebecca Fischer-Betz
    Department of Endocrinology, Heinrich Heine University, Duesseldorf, Germany
    Clin Exp Rheumatol 29:1021-3. 2011
    ..So far, there are scant data available on the effects of anakinra in pregnancy. We report two patients with AOSD who successfully gave birth while treated with anakinra during pregnancy...
  11. doi request reprint [Inflammation-related cardiovascular morbidity : Pathophysiology and therapy]
    R Fischer-Betz
    Rheumazentrum Rhein Ruhr, Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Heinrich Heine Universitat Dusseldorf, Deutschland
    Z Rheumatol 69:680-4, 686-8. 2010
    ..Any CV risk factors identified should be optimally managed. In addition to appropriate CV risk management, aggressive suppression of the inflammatory process is recommended to further lower CV risk...
  12. doi request reprint [Pregnancy and inflammatory rheumatic diseases]
    R Fischer-Betz
    Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Rheumazentrum Rhein Ruhr, 40225 Dusseldorf, Deutschland
    Z Rheumatol 69:633-41; quiz 642-3. 2010
    ..To ensure a favorable outcome, pregnancy should be planned to take place during a period of disease stability, monitored closely (physical examination, laboratory tests, and Doppler ultrasound), and treated appropriately...
  13. doi request reprint [Antimalarials. A treatment option for every lupus patient!?]
    R Fischer-Betz
    Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225, Dusseldorf, Deutschland
    Z Rheumatol 68:584, 586-90. 2009
    ..Particularly in early disease phases, antimalarials should be considered for every lupus patient, assuming there are no contraindications...
  14. ncbi request reprint [Modern therapy for systemic lupus erythematosus]
    R Fischer-Betz
    Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Heinrich Heine Universitat, Moorenstrasse 5, 40225, Dusseldorf, Germany
    Z Rheumatol 66:662-6, 668-71. 2007
    ..With regard to new future therapies, we refer the reader to other current publications...
  15. ncbi request reprint [Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Comment on the use of mycophenolic acid for systemic lupus erythematosus]
    R Fischer-Betz
    Z Rheumatol 66:78-82. 2007
    ..In addition, the duration of maintenance therapy is unclear. Therefore, large, prospective, randomized clinical studies in the treatment of lupus-nephritis with a sufficiently long follow-up phase are underway...
  16. ncbi request reprint [Lupus in Germany: analysis within the German lupus self-help organization (LULA)]
    R Fischer-Betz
    Rheumazentrum Düsseldorf, Heinrich Heine Universitat, Moorenstrasse 5, 40225 Dusseldorf, Germany
    Z Rheumatol 64:111-22. 2005
    ..Further assessment especially of long-term data are needed to obtain additional insights into the burden of the disease and the need for special medical care...
  17. ncbi request reprint Connective tissue diseases: evaluation of clinical response
    R Fischer-Betz
    Heinrich Heine Universität Duesseldorf, Moorenstr 5, 40225 Duesseldorf, Germany
    Rheumatology (Oxford) 45:iii5-7. 2006
    ..In individual patients, there is need for a more organ-specific evaluation, and non-disease-specific and/or global health instruments may be used in evaluating the response of individual treatment regimen...
  18. ncbi request reprint [Systemic lupus erythematosus]
    R Fischer-Betz
    Klinik für Diabetologie, Endokrinologie und Rheumatologie, Rheumazentrum Düsseldorf, Heinrich Heine Universitat
    Dtsch Med Wochenschr 130:2451-8; quiz 2459-60, 2461-2. 2005
  19. pmc First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104
    C Iking-Konert
    Rheumazentrum Duesseldorf, Heinrich Heine University Duesseldorf, Germany
    Ann Rheum Dis 63:1104-12. 2004
    ..The heteropolymer technology was developed to remove pathogens from the circulation...
  20. ncbi request reprint [Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?]
    R Fischer-Betz
    Rheumazentrum Düsseldorf, Heinrich Heine Universitat, Moorenstrasse 5, 40225, Dusseldorf, Germany
    Z Rheumatol 64:229-38. 2005
    ....
  21. ncbi request reprint [Guidelines for assessment of patients with connective tissue diseases]
    O Sander
    Rheumazentrum Düsseldorf, Klinik fur Nephrologie und Rheumatologie, Heinrich Heine Universitat Dusseldorf, Moorenstr 5, 40225 Dusseldorf, Germany
    Z Rheumatol 61:652-60. 2002
    ..This article is a guideline reflecting published data, modern therapy and actual prognosis. In addition, help for interpretation and examples are given...
  22. pmc Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study
    M Haupt
    Centre of Rheumatology, Heinrich Heine University Dusseldorf, Moorenstr 5, 40225 Dusseldorf, Germany
    Ann Rheum Dis 64:1618-23. 2005
    ..To evaluate a novel specific psychological intervention aimed at improving coping in patients with systemic lupus erythematosus (SLE)...
  23. ncbi request reprint [Disability in lupus erythematosus]
    O Sander
    Rheumazentrum Düsseldorf an der Universität
    Versicherungsmedizin 58:120-5. 2006
    ..In conclusion the data demonstrate a fair appraisal of disability by the German welfare system in patients with LE. Self-administered questionaires can yield credible results...
  24. ncbi request reprint Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres
    A Zink
    Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany
    Lupus 13:529-36. 2004
    ..The great disparity in treatment intensity between rheumatologists and nonrheumatologists shows that the involvement of a specialist is needed equally in both diseases...
  25. ncbi request reprint [Anti-CD20 therapy for inducing and maintaining remission in refractory systemic lupus erythematosus]
    G Chehab
    Rheumazentrum Düsseldorf, Klinik fur Endokrinologie, Diabetologie und Rheumatologie, Heinrich Heine Universitat Dusseldorf, Moorenstrasse 5, 40225 Dusseldorf
    Z Rheumatol 66:328, 330-6. 2007
    ..The selective depletion of B-lymphocytes in the therapy of systemic lupus erythematosus seems to be an effective and safe treatment option for different manifestations...